|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/12 | |
| B65D 83/00 |
| (11) | Number of the document | 1658105 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04782101.2 |
| Date of filing the European patent application | 2004-08-25 | |
| (97) | Date of publication of the European application | 2006-05-24 |
| (45) | Date of publication and mention of the grant of the patent | 2018-03-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2004/027539 |
| Date | 2004-08-25 |
| (87) | Number | WO 2005/023330 |
| Date | 2005-03-17 |
| (30) | Number | Date | Country code |
| 499250 P | 2003-08-29 | US |
| (72) |
Miller, John F., GlaxoSmithKline, US
Sommerville, Mark L., GlaxoSmithKline, US
Schultz, Robert D., GlaxoSmithKline, US
|
| (73) |
GLAXO GROUP LIMITED,
980 Great West Road Brentford, Middlesex TW8 9GS,
GB
|
| (54) | PHARMACEUTICAL METERED DOSE INHALER AND METHODS RELATING THERETO |
| PHARMACEUTICAL METERED DOSE INHALER AND METHODS RELATING THERETO |